China officially begins using domestically produced nine-valent HPV vaccine

Translation. Region: Russian Federal

Source: People's Republic of China in Russian – People's Republic of China in Russian –

An important disclaimer is at the bottom of this article.

Source: People's Republic of China – State Council News

BEIJING, Sept. 10 (Xinhua) — China has officially started using a domestically produced nine-valent human papillomavirus (HPV) vaccine as the first dose of the vaccine was administered in Xiamen, east China's Fujian Province, on Tuesday.

Mass HPV vaccination will provide more comprehensive and accessible prevention of cervical cancer in women aged 9 to 45 years.

Cervical cancer is one of the most common cancers in women worldwide, and an estimated 700,000 cases of cancer are linked to HPV each year, including about 530,000 cases of cervical cancer, with the remainder being of the anus, vulva, penis and others.

Vaccination is an important line of defense. When used correctly, the vaccine is 94 percent effective in preventing HPV infection. -0-

Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.

.